News and Resources

Dexpramipexole Kv 7 Company News

All
Presentations
Publications

08.04.18

American Society of Hematology: “Dexpramipexole: a new antieosinophil drug?”

Discover this News

01.01.18

American Society of Hematology: “Dexpramipexole as an oral steriod-sparing agent in hypereosinophilic syndromes”

Discover this News

01.01.18

The Laryngoscope: “Dexpramipexole Depletes Blood and Tissue Eosinophils in Nasal Polyps”

Discover this News

01.16.17

Elsevier: “The targeted eosinophil-lowering effects of dexpramipexole in clinical studies”

Discover this News

Knopp Disclaimer

Knopp’s pipeline consists of investigational drug products that have not been approved by the U.S. Food and Drug Administration. These investigational drug products are undergoing clinical study to verify their safety and effectiveness.

News and Resources

Learn More About the Unmet Needs We Strive to Address

Keep Up with Knopp, See What We Are Doing Next.

Knopp Disclaimer